CRP and early-onset autosomal dominant Alzheimer disease: Increased levels of circulating C-reactive protein (CRP) have been correlated with changes in brain metabolites indicating early brain vulnerability [23], and serum CRP levels has also been shown to be elevated in patients with mild cognitive impairment, a prodromal stage of Alzheimer’s disease [24].